May 8, 2023 7:00am EDT Tonix Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights
May 4, 2023 7:00am EDT Tonix Pharmaceuticals Announces IND Clearance for TNX-1500 (anti-CD40L mAb) for the Prevention of Organ Rejection in Patients Receiving a Kidney Transplant
Apr 19, 2023 7:00am EDT Tonix Pharmaceuticals Announces Presentations of Pre-Clinical Data on TNX-1700 in Syngeneic Models of Colorectal and Gastric Cancer at the American Association for Cancer Research Annual Meeting 2023
Apr 17, 2023 7:00am EDT Tonix Pharmaceuticals Announces Two Publications of Data in American Journal of Transplantation Showing TNX-1500 (anti-CD40L mAb) Prolongs Nonhuman Primate Renal and Heart Allograft Survival
Apr 6, 2023 4:15pm EDT Tonix Pharmaceuticals Presents Data from its Vaccine Development Program at the World Vaccine Congress
Apr 5, 2023 7:00am EDT Tonix Pharmaceuticals Announces Poster Presentations at the American Association for Cancer Research Annual Meeting 2023
Mar 30, 2023 7:00am EDT Tonix Pharmaceuticals Presents Positive Efficacy and Safety Data from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 5th International Congress on Controversies in Fibromyalgia
Mar 27, 2023 7:00am EDT Tonix Pharmaceuticals Announces Oral Presentations at the World Vaccine Congress
